ESTOMATOLOGÍA
DEPARTAMENTO
ENCARNACIÓN
GONZÁLEZ RODRÍGUEZ
Investigadora no período 1994-2022
Publicacións nas que colabora con ENCARNACIÓN GONZÁLEZ RODRÍGUEZ (69)
2024
-
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
Clinical and Translational Oncology
-
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study
Clinical and Translational Oncology
-
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study
Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2217-2226
-
Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review
Clinical and Translational Oncology, Vol. 26, Núm. 4, pp. 851-863
-
Retrospective registry of patients with locally advanced/metastatic HR+/HER2− breast cancer treated in clinical practice in Andalusia
Clinical and Translational Oncology
-
Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer
International Journal of Molecular Sciences, Vol. 25, Núm. 1
-
SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023)
Clinical and Translational Oncology
-
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
Clinical and Translational Oncology
2023
-
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
Pharmaceutics, Vol. 15, Núm. 11
-
Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review
Cancers, Vol. 15, Núm. 6
-
Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis
NMR in Biomedicine, Vol. 36, Núm. 9
2022
-
Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 4, pp. 231-238
-
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
European Journal of Surgical Oncology, Vol. 48, Núm. 5, pp. 1123-1132
2021
-
Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer
Journal of Clinical Medicine, Vol. 10, Núm. 11
-
Controversies in the treatment of RAS wild-type metastatic colorectal cancer
Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 827-839
-
Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (Isoflux) and imaging flow cytometry (imagestream)
Cancers, Vol. 13, Núm. 24
-
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)
ESMO Open, Vol. 6, Núm. 2
-
Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)
ESMO open, Vol. 6, Núm. 4, pp. 100215
-
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept
Clinical and Translational Oncology, Vol. 23, Núm. 8, pp. 1520-1528
2020
-
Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM
Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 647-662